Search Results
Aug 13, 2025, 02:02 ET Компания TCL побуждает жизнь нового поколения, демонстрируя передовые технологии на выставке IFA 2025
революционные инновации, которые коренным образом меняют современную жизнь. Гости познакомятся с передовыми технологиями, включая новейшие сверхбольшие дисплеи QD-Mini LED, технологию отображения NXTPAPER, очки дополненной реальности, бытовые приборы с поддержкой ИИ, такие как кондиционеры, стиральные машины, холодильники
More news about: TCL
Aug 12, 2025, 21:53 ET TCL Wujudkan Gaya Hidup Generasi Baru Lewat Teknologi Mutakhir di IFA 2025
akan memamerkan berbagai inovasi terkini yang mengubah kehidupan modern. Para pengunjung dapat mencoba berbagai teknologi mutakhir, termasuk layar LED QD-Mini terbaru dengan layar ultra-large, teknologi layar NXTPAPER, kacamata AR, perangkat rumah tangga yang didukung AI, seperti penyejuk udara,
More news about: TCL
Aug 12, 2025, 19:00 ET Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model
Tirzepatide, 3 nmol/kg, SQ, QD -20.4 %
More news about: Ascletis Pharma Inc.
Aug 12, 2025, 13:23 ET TCL estimula a vida da próxima geração com apresentação de tecnologia de ponta na IFA 2025
recentes inovações revolucionárias que redefinem a vida moderna. Os visitantes experimentarão tecnologias de ponta, incluindo os mais recentes displays QD-MINI LED ultragrandes, tecnologia de exibição NXTPAPER, óculos AR, aparelhos alimentados por IA, como condicionadores de ar, máquinas de lavar, refrigeradores
More news about: TCL
Aug 12, 2025, 13:19 ET TCL impulsa la vida de la próxima generación con una exhibición tecnológica de vanguardia en la IFA 2025
innovaciones revolucionarias que redefinen la vida moderna. Los visitantes experimentarán tecnologías de vanguardia que incluyen las últimas pantallas QD-Mini LED ultra grandes, la tecnología de pantalla NXTPAPER, las gafas de realidad aumentada, los electrodomésticos con IA, como aires acondicionados,
More news about: TCL
Aug 12, 2025, 07:13 ET TCL zapowiada nową generację życia, prezentując najnowocześniejsze technologie na targach IFA 2025
definiują współczesne życie. Odwiedzający będą mogli zapoznać się z najnowocześniejszymi technologiami, w tym najnowszymi ultradużymi wyświetlaczami QD-Mini LED, technologią wyświetlania NXTPAPER, okularami AR, urządzeniami opartymi na sztucznej inteligencji, takimi jak klimatyzatory, pralki, lodówki
More news about: TCL
Aug 12, 2025, 07:05 ET TCL představí na veletrhu IFA 2025 technologie budoucnosti pro moderní bydlení
průlomové inovace, které posouvají hranice moderního bydlení. Návštěvníci se mohou těšit na špičkové technologie, včetně nejnovějších ultra velkých displejů QD-Mini LED, technologie displejů NXTPAPER, brýlí pro rozšířenou realitu a spotřebičů s podporou umělé inteligence – od klimatizací přes pračky a chladničky
More news about: TCL
Aug 12, 2025, 07:01 ET TCL leitet mit Präsentation modernster Technologie auf der IFA 2025 nächste Generation des Wohnens ein
Innovationen vorstellen, die das moderne Leben neu definieren. Die Besucher werden modernste Technologien erleben, darunter die neuesten ultragroßen QD-Mini-LED-Displays, die NXTPAPER-Displaytechnologie, AR-Brillen, KI-gesteuerte Geräte wie Klimaanlagen, Waschmaschinen, Kühlschränke und mehr, die zusammen das
More news about: TCL
Aug 12, 2025, 06:55 ET TCL s'apprête à mettre le feu aux poudres au salon IFA 2025 avec une vitrine technologique de pointe de ses équipements de nouvelle génération
innovations révolutionnaires qui redéfinissent la vie moderne. Les visiteurs découvriront des technologies de pointe, notamment les derniers écrans à LED QD-Mini ultralarges, la technologie d'affichage NXTPAPER, les lunettes de réalité augmentée, les climatiseurs, lave-linge, réfrigérateurs alimentés par
More news about: TCL
Aug 12, 2025, 06:52 ET TCL predstavuje bývanie novej generácie s najmodernejšími technológiami na veľtrhu IFA 2025
inovácie, ktoré nanovo definujú moderný životný štýl. Návštevníci spoznajú najmodernejšie technológie vrátane najnovších ultra veľkých LED displejov QD-Mini, technológie displejov NXTPAPER, okuliarov AR, spotrebičov s AI, ako sú klimatizácie, práčky, chladničky a ďalšie, ktoré preukazujú záväzok značky
More news about: TCL
Aug 12, 2025, 06:49 ET TCL impulsa la vida de nueva generación con una exhibición de tecnología de vanguardia en IFA 2025
las últimas innovaciones revolucionarias que redefinen la vida moderna. Los visitantes experimentarán tecnologías de vanguardia, como las pantallas LED QD-Mini ultragrandes, la tecnología de pantalla NXTPAPER, gafas de realidad aumentada (RA), electrodomésticos con inteligencia artificial como aires acondicionados,
More news about: TCL
Aug 12, 2025, 05:09 ET TCL, IFA 2025에서 최첨단 기술로 차세대 라이프스타일 선보여
TCL은 IFA 2025에서 현대 생활을 재정의하는 최신 혁신 기술을 공개한다. 방문객들은 개인화되고 지속 가능한 지능형 생활 솔루션에 대한 TCL의 헌신을 보여주는 ▲최신 초대형 QD-Mini LED 디스플레이 ▲NXTPAPER 디스플레이 기술 ▲AR 안경 ▲AI 가전제품(에어컨, 세탁기, 냉장고 등) 등 최첨단 기술을 체험할 기회를 누릴 수 있게 된다. 방문객들은 또 최신 TCL 기술로 구현된 일련의 몰입형 공간을 통해 TCL이
More news about: TCL
Aug 12, 2025, 00:48 ET TCL Ignites Next-Gen Living with Cutting-Edge Tech Showcase at IFA 2025
the latest groundbreaking innovations that redefine modern living. Visitors will experience cutting-edge technologies including the latest ultra-large QD-Mini LED displays, NXTPAPER display technology, AR Glasses, AI-powered appliances such as air conditioners, washing machines, refrigerators and more
More news about: TCL
Aug 12, 2025, 00:19 ET TCL Ignites Next-Gen Living with Cutting-Edge Tech Showcase at IFA 2025
the latest groundbreaking innovations that redefine modern living. Visitors will experience cutting-edge technologies including the latest ultra-large QD-Mini LED displays, NXTPAPER display technology, AR Glasses, AI-powered appliances such as air conditioners, washing machines, refrigerators and more
More news about: TCL
Aug 11, 2025, 12:58 ET TCL Offers Amazing Deals on QD Mini-LED TVs for 2025 NFL Season
award-winning television lineup. Over the next two months, the official TV of the NFL, TCL is providing up to 50% off on its award-winning lineup of QD Mini-LED TVs and other top models – perfect for enjoying the upcoming 2025 NFL season.
More news about: TCL North America
Jul 10, 2025, 08:36 ET IEEE Study Achieves Efficient Integration of Quantum Dot Lasers on Silicon Chiplets
University of California, United States, and her team successfully integrated indium arsenide quantum dot (QD) lasers monolithically on silicon photonics chiplets. According to Dr. Koscica, "Photonic integrated circuit applications call for on-chip light sources
More news about: IEEE Photonics Society
Jul 09, 2025, 09:00 ET UbiQD and First Solar Establish Long-Term Quantum Dot Supply Agreement
2025 /PRNewswire/ -- UbiQD®, a global leader in quantum dot (QD) nanotechnology, announced today that it has entered into an exclusive, multi-year agreement to supply its proprietary fluorescent QD technology to
More news about: UbiQD, Inc.
Jul 08, 2025, 09:38 ET Dive into Savings this Amazon Prime Day with AiRROBO's Top-Tier Cleaning Deals
AiRROBO T20 Self-Emptying Mop Combo Robot Vacuum – $179.99 (Code: 8Q9425QD) Experience hands-free cleaning with the AiRROBO T20, a smart robot vacuum and mop combo that redefines convenience: 360° LiDAR
More news about: AiRROBO
Jul 03, 2025, 21:35 ET 5 innovaciones de pantallas que ya están sorprendiendo a la industria
existentes. Esta tecnología está certificada por TÜV Rheinland, por cumplir con los estándares internacionales para una pantalla de puntos cuánticos (QD) auténtica. Esta certificación TÜV subraya el liderazgo de Samsung en la fabricación de paneles con una pureza de color, un brillo y un rendimiento duradero
More news about: Samsung Mexico
Jun 30, 2025, 08:00 ET Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
sites primarily in the United States. Participants will be randomized initially to treatment with TYRA-300 at 50 mg once daily (QD) (Cohort 1) or treatment with TYRA-300 at 60 mg QD (Cohort 2). Following a review of efficacy and safety, an additional dosing cohort may be evaluated. The primary endpoint
More news about: Tyra Biosciences
Jun 25, 2025, 12:49 ET Samsung presenta innovaciones en IA para pantallas, barras de sonido y monitores en el 2025 LATAM Visual Display Seminar
certificada por TÜV Rheinland certificada por TÜV Rheinland, otorgada por cumplir con los estándares internacionales para una pantalla de puntos cuánticos (QD) auténtica. Esta certificación TÜV subraya el liderazgo de Samsung en la fabricación de paneles con una pureza de color, un brillo y un rendimiento duradero
More news about: Samsung Mexico
Jun 24, 2025, 06:30 ET Nuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC
trial for patients with advanced ROS1-positive NSCLC and other solid tumors. The recommended phase 2 dose (RP2D) for zidesamtinib of 100 mg once daily (QD) was determined during the Phase 1 dose-escalation portion of the trial. The ongoing global, single arm, multi-cohort, open label Phase 2 portion is
More news about: Nuvalent, Inc.
Jun 13, 2025, 09:00 ET Regor to Present Data on its Lead Obesity Candidate, RGT-075, at the 85th Scientific Sessions of American Diabetes Association (ADA)
with weight-related comorbidities. The trial has enrolled approximately 240 participants. All participants on RGT-075 will be given RGT-075 once daily (QD) titrated up over 12 weeks. The primary endpoint is percent change in body weight from baseline to week 36. Secondary endpoints include safety and tolerability
More news about: Regor Therapeutics
Jun 13, 2025, 06:02 ET Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML at EHA 2025 Congress
April 28, 2025, 90 patients have been enrolled in the ongoing Phase 1 trial across dose levels ranging from 10 mg once a day (QD) to 80 mg twice a day (BID).The vast majority of patients (80%) remain on study with a median treatment duration of ~29 weeks.Patients
More news about: Enliven Therapeutics, Inc.
Jun 12, 2025, 06:13 ET Dizal Showcases Two First-in-Class Therapies in Hematologic Malignancies at EHA and ICML 2025
both BTK and LYN signaling pathways, and thus potentially improve therapeutic outcomes. At recommended phase 2 doses (RP2Ds) of 50 mg and 75 mg QD, DZD8586 monotherapy demonstrated promising anti-tumor activity in r/r DLBCL. The majority of patients showed target lesion
More news about: Dizal Pharmaceutical